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Abstract
We have shown that epoxyeicosatrienoic acids (EETs), specifically 11,12- and 14,15-EETs, reduce 
adipogenesis in human mesenchymal stem cells and mouse preadipocytes (3T-3L1). In this study, 
we explore the effects of soluble epoxide hydrolase (sEH) deletion on various aspects of 
adipocyte-function, including programing for white vs. beige-like fat, and mitochondrial and 
thermogenic gene-expressions. We further hypothesize that EETs and heme-oxygenase 1 (HO-1) 
form a synergistic, functional module whose effects on adipocyte and vascular function is greater 
than the effects of sEH deletion alone. In in vitro studies, we examined the effect of sEH inhibitors 
on MSC-derived adipocytes. MSC-derived adipocytes exposed to AUDA, an inhibitor of sEH, 
exhibit an increased number of small and healthy adipocytes, an effect reproduced by siRNA for 
sEH. in vivo studies indicate that sEH deletion results in a significant decrease in adipocyte size, 
inflammatory adipokines NOV, TNFα, while increasing adiponectin (p < 0.05). These findings are 
associated with a decrease in body weight (p < 0.05), and visceral fat (p < 0.05). Importantly, sEH 
deletion was associated with a significant increase in Mfn1, COX 1, UCP1 and adiponectin (p < 
0.03). sEH deletion was manifested by a significant increase in EETs isomers 5,6-EET, 8,9-EET, 
11,12-EET, and 14,15-EET and an increased EETs/DHETEs ratio. Notably, activation of HO-1 
gene expression further increased the levels of EETs, suggesting that the antioxidant HO-1 system 
protects EETs from degradation by ROS. These results are novel in that sEH deletion, while 
increasing EET levels, resulted in reprograming of white fat to express mitochondrial and 
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thermogenic genes, a phenotype characteristic of beige-fat. Thus, EETs agonist(s) and sEH 
inhibitors may have therapeutic potential in the treatment of metabolic syndrome and obesity.
Keywords
Heme Oxygenase; PGC-1 coactivators; Oxidative phosphorylation; Uncoupling protein 1 (UCP1); 
Mitochondrial protein
1. Introduction
Metabolic disorders, such as obesity, diabetes, hypertension and cardiovascular disease, have 
become more of an epidemic in recent years. Obesity is characterized by a pathological 
increase in white fat, associated with high levels of inflammation, insulin resistance and 
mitochondrial dysfunction, contributing to diabetes, hypertension and even heart failure [1]. 
Several studies indicate that browning of white fat can ameliorate obesity and associated 
metabolic disorders [2]. Beige and brown fat, which contains small adipocytes, dissipate 
energy as heat, resulting in the burning of calories and a potential weight loss in mice and 
humans [3,4]. Therefore, increasing thermogenic genes and mitochondrial function could 
result in the transformation of white-fat to beige-fat.
Adipose tissue function is controlled by several processes including mitochondrial 
biogenesis and adaptive thermogenesis, highlighting the essential role of mitochondrial 
function in adipocytes. Adipocyte mitochondria are deficient in insulin-resistant individuals 
and correlate with systemic lipid metabolism, inflammation and insulin sensitivity [5]. The 
function of the mitochondrial network depends on quality control, referred to fusion and 
fission. Mitofusin 1 and 2 (Mfn1 and Mfn2) facilitate the mitochondrial fusion process [6] 
while COX-1 is related to mitochondrial oxidative phosphorylation (OXPHOS) [7]. Brown 
adipose tissue generates heat by uncoupling respiration with its unique mitochondrial 
membrane embedded protein UCP1, a process known as non-shivering thermogenesis [8], 
which increases heat production through an uncoupling of oxidative metabolism from ATP 
production [9].
Epoxyeicosatrienoic acids (EETs) are arachidonic acid derived lipid mediators with 
beneficial effects on metabolic and cardiovascular health [10]. EETs are derived from 
arachidonic acid by a CYP pathway, predominately mammalian CYP epoxygenases, 
resulting in four separate regioisomers of EETs [11]. EETs are rapidly degraded by soluble 
epoxide hydrolase (sEH), which exists in mammalian tissues, including the myocardium, 
kidney, liver, adipose and blood vessels [12]. sEH is known to play a pro-inflammatory role 
during inflammation by metabolizing EETs to DHETs [13]. This results in the degradation 
of endogenous anti-inflammatory EET’s. Our recent research indicated that EETs 
upregulates the heme-HO system [3,14,15], mitochondrial function, as well as 
thermogenesis which have a profound effect on improving adipocyte function [16]. The HO 
system represents an important protective mechanisim in the cardiovascular and metabolic 
system(s) against the harmful effects of oxidative stress [17,18].
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Clinical studies have shown that sEH gene polymorphism is associated with insulin 
resistance (IR) [19], and IR is the one of the key features in obesity. IR is accompanied by 
increased reactive oxygen species (ROS) in adipocytes, release of a series of redox and 
inflammatory mediators, and creation of large, dysfunctional adipocytes [20]. 
Overexpression of sEH in non-diabetic mice resulted in similar vessel abnormalities as 
diabetic mice with retinopathy [21]; whereas, inhibition of sEH suppressed inflammation in 
cardiovascular disease [22]. Recently, we have shown that upregulation of EETs can 
increases HO-1 expression; leading to a reduction in fatty acid synthesis, conversion of large 
adipocytes to small adipocytes and a decrease in body weight [23].
In our present study, we explored the relationship of sEH-inhibition and mitochondrial gene-
expression with regard to genes involved in thermogenesis. We have also examined the 
functional EET-HO-1 module and its effects, if any, on EET production and phenotype of 
sEH knockout mice. Our results demonstrate that sEH knockdown augments the pro-
thermogenic profile of adipose tissue mitochondria with significantly reduced adipose tissue 
burden, effects further accentuated by HO-1-induction.
2. Methods
2.1. Differentiation of human bone marrow-derived MSCs into adipocytes
Frozen bone marrow mononuclear cells were purchased from Allcells (Allcells, Emeryville, 
CA, USA). After thawing, mononuclear cells were re-suspended in a-minimal essential 
medium (a-MEM, Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat-in-
activated fetal bovine serum (FBS, Invitrogen) and 1% antibiotic/antimycotic solution 
(Invitrogen). The cells were plated at a density of 1 to 5 × 10 [6] cells per 100-cm2 dish. The 
medium was replaced with adipogenic medium, and the cells were cultured for an additional 
14 days as described previously [24]. The cells were treated with 11, 12-EET and 14, 15-
EET (1 μM) alone and with sEH inhibitor (AUDA) (1 μM), or with sEH siRNA using an N-
TER kit (Sigma-Aldrich, St. Louis, MO) according to manufacturer’s protocol.
2.2. Oil Red O staining
For Oil Red O staining, 0.21% Oil Red O in 100% isopropanol (Sigma-Aldrich, St. Louis, 
MO) was used. Briefly, adipocytes were fixed in 10% formaldehyde, stained in Oil red O for 
10 min, rinsed with 60% isopropanol (Sigma–Aldrich, St. Louis, MO), and the Oil red O 
eluted by adding 100% isopropanol for 10 min and OD measured at 490 nm.
2.3. Animal protocols
Male sEH null mice were provided by Dr. Darryl C. Zeldin at age of 12 weeks. Aged-
matched B6129SF2/J mice served as controls. Mice were fed a normal chow diet and had 
free access to water, no difference in food intake was observed between different groups. All 
mice were divided in to 3 groups; 1) Control; 2) sEH KO male mice; 3) sEH KO + CoPP 
male mice. Cobalt protoporphyrin IX (CoPP) (3 mg/kg once a week) was administered i.p. 
for 8 weeks. Measurement of body weight was made during the course of the study. At 
sacrifice, aorta and adipocyte tissues were immediately collected, weighed and stored at 
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−80 °C until use. The Animal Care and Use Committee of New York Medical College 
approved all experiments.
2.4. RNA, protein signaling, and EET measurement
After collecting all the samples, we use RT-PCR to measure gene expression in both cells 
and tissue. Total RNA was isolated using Trizol® (Invitrogen, Carlsbad, CA) according to 
the manufacturer’s instructions [23,25]. Protein signals were measured as previously 
described [14]. EETs were extracted using solid phase C18-ODS AccuBond II 500-mg 
cartridges, where after EET levels were analyzed by LC–MS/MS as described [26].
2.5. Measurement of superoxide in aorta tissues
Samples were placed in scintillation mini vials containing 5 mm of lucigenin and 1 ml of 
Krebs solution buffered (pH 7.4). Lucigenin chemiluminescence was measured in a liquid 
scintillation counter (LS6000IC; Beckman Instruments, San Diego, CA) at 37 °C; data are 
reported as counts/min/mg protein after background subtraction.
2.6. Statistical analysis
All values are presented as mean ± SE. Statistical significance between experimental groups 
was determined by the Fisher method of analysis of multiple comparisons (p < 0.05). For 
comparison between treatment groups, the null hypothesis was tested by a single-factor 
ANOVA for multiple groups or unpaired t-test for two groups, p < 0.05 was regarded as 
significant.
3. Results
3.1. Effect of EETs and sEH inhibition on oil droplet formation in MSCs derived 
adipocytes
To elucidate the role of EETs in the regulation of adipogenesis during MSCs differentiation 
to adipocyte lineage, we measured the effect of EETs administration and suppression of sEH 
on adipogenesis. Daily supplementation of 11, 12-, and 14, 15-EETs was effective on 
adipogenesis suppression at 14 days. Inhibition of sEH with AUDA, showed a significant (p 
< 0.05) and synergistic reduction of lipid droplet formation in MSC-derived adipocytes (Fig. 
1).
3.2. Effect of sEH deletion on oil droplet formation
As shown in Fig. 2, ablation of sEH significantly (p < 0.05) decreased lipid droplets size in 
MSC derived adipocytes. The percentage of cells with morphological lipid droplets 
decreased following silencing of sEH. The adipocyte cell size in the absence of siRNA was 
± pixels compared with ± pixels in the presence of siRNA (Fig. 2).
3.3. Effect of sEH knockout on Inflammatory Cytokine levels in adipose tissue
RT_PCR analysis showed a significant (p < 0.05) increase in HO-1 mRNA expression in 
adipose tissue of sEH KO mice as compared to WT control mice (Fig. 3A), the mRNA 
expression of inflammatory cytokines such as NOV and TNFα were significantly (p < 0.05) 
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lower in sEH KO mice compared to control (Fig. 3B and 3C), These results indicate that 
deletion of sEH leads to HO-1 induction resulting in a decrease of inflammation.
3.4. Effect of sEH knockout on mitochondrial function and thermogenic genes
Mitochondrial fusion is essential for mitochondrial function, therefore, to examine whether 
sEH can modulate the mitochondrial fusion-to-fission ratio, we measured Mfn1 and Mfn2 
levels in adipose tissue of sEH KO mice. There was a significant (p < 0.05) increase in Mfn1 
mRNA expression in sEH KO mice compared to control. However, there was no significant 
change in Mfn2 expression (Fig. 3D and E). Furthermore, levels of cytochrome c oxidase 
subunit I (COX-I) were significantly (p < 0.05) higher in KO mice (Fig. 3F), and expression 
of FIS1 was not significantly different between groups (Fig. 3G). Our analysis demonstrated 
that UCP1 mRNA expression levels were significantly increased in sEH KO mice compared 
to control mice (Fig. 3H). Moreover, adiponectin mRNA expression significantly increased 
(p < 0.05) in sEH KO mice (Fig. 3I).
In agreement with results from fat tissue, we observed a significant (p < 0.05) increase in 
Mfn1 (Fig. 4A) as well as in HO-1 (Fig. 4B) expression in the aortas of sEH KO mice as 
compared to control. These results indicate that deletion of sEH resulted in an increase in 
mitochondrial function. To investigate the effect of sEH deletion on lipid metabolism, we 
analyzed the expression of thermogenic markers which characterize brown adipocytes.
3.5. Effect of sEH ablation and HO-1 induction on superoxide formation
Ablation of sEH and HO-1 induction significantly (p < 0.05) reduced superoxide anion 
formation in aortas of mice compared to both KO sEH and WT control (Fig. 4C).
3.6. Effect of sEH ablation with and without HO-1 Inducer on adiposity
As seen in Fig. 5, deletion of sEH decreased body weight in male null mice compared to 
control. Pictures of mice indicate that sEH KO mice are leaner than the control group (Fig. 
5A). Body weight of KO mice was 28.8 ± 7.28 g compared with 36.17 ± 0.77 g in control 
mice (Fig. 5B). To further increase the antioxidant functions of EETs, we treated sEH KO 
mice with a well-known HO-1 inducer cobalt Protoporphyrin (CoPP) an inducer of HO-1. 
Western blot analysis showed a significant (p < 0.05) increase in HO-1 protein expression in 
adipose tissue of sEH KO mice as compared to WT control mice, this increase was even 
more significant when CoPP was administered to sEH KO mice (Fig. 5C). The body weight 
in sEH null mice was similar to the sEH + CoPP group.
3.7. Effect of sEH ablation and HO-1 induction on EETs levels
The levels of isoforms of EETs (5, 6-EET, 8, 9-EET, 11, 12-EET, 14, 15-EET) and that total 
EETs (2.32 ± 0.22 mg vs. 0.61 ± 0.06 mg) were significantly (p < 0.05) increased in sEH 
KO mice compared to control mice. Since not all EETs are released as functional EETs, we 
administered CoPP to sEH KO mice. As a result, there was a significant increase in all forms 
of EETs (5, 6-EET, 8, 9-EET, 11, 12-EET, 14, 15-EET) as well as of total EETs levels 
compared to control mice and sEH KO without CoPP treatment (Fig. 6A–F).
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4. Discussion
This study demonstrates that EETs improve adipocyte structure and function via 
upregulation of mitochondrial thermogenic genes, and restore redox and inflammatory 
balance in adipose tissues. We also establish the operational nature of the HO-EET 
synergistic module by demonstrating elevated EET levels in sEH KO mice treated with 
CoPP and by an improved phenotype in these mice (Fig. 7).
The first key finding of the study is the rescue of adipocyte function by sEH inhibitors and 
knockdowns. Our results demonstrates that the production of the pro-inflammatory 
adipokine, NOV, is attenuated by sEH deletion as well as by increased levels of HO-1. We 
also found that the level of mitochondrial signaling; Mfn1 increased in sEH KO mice. 
Furthermore, there was an increase of COX-1 in the adipose tissue of KO mice indicating 
that sEH deletion and increases of EET levels plays a crucial role in mitochondrial integrity 
and fat phonotype (Fig. 7). Previous studies indicate that HO-1 induction decreases ROS 
formation as well as controls adiposity in transgenic mice [27]. In our current study we 
showed that increasing EETs through inhibition of sEH leads to diminished MSC-derived 
adipocyte terminal differentiation, decreased lipid droplet formation and inhibition of 
adipogenesis. In agreement with published reports [28–30], increase of EET as result of 
inhibition of sEH in adipocytes can turn large unhealthy adipocytes into small healthy 
adipocytes. In fact levels of EET in pre = adipocyte is higher than EET Levels in fully 
mature adipocyte [24,30]. This is further strengthened by the fact that inhibition of sEH 
increases thermogenic genes; UCP1 expression, suggesting a transformation of white fat to 
beige or brown fat.
The second key finding of this study derives from our in vivo experiments where we found 
that ablation of sEH decreased the degradation of EETs leading to increased antioxidants, 
anti-inflammatory and lipid lowering effects, as well as the body size and weight reduction 
of sEH KO mice, both with and without treatment with CoPP, an inducers of HO-1. HO-1 
induction increased EET which led to weight loss and decreased fat deposition. The results 
regarding adipose tissue loss and reduced body weight in sEH null mice and associated 
increases in total EET-levels are confirmed by our previous studies with total body MRI in 
which reduction of adipose tissue was confirmed [31–33]. We do not know why increased 
levels of HO-1 by CoPP administration did not result in any additional weight loss, possibly 
the mice reached the lowest level of fat so that additional weight loss was not possible. 
Obesity and metabolic syndrome, characterized by body weight gain, low level 
inflammation and oxidative stress overexpression, is associated with hyperlipidemia, insulin 
resistance and cardiovascular diseases [1]. Recent research indicated that white fat increased 
in obesity and was accompanied with inflammation [1,18,28,34]. the amelioration of renal 
inflammation will reduce hypertension and type II diabetes [35]. A chronic high fat diet 
increased expression of adipose sEH protein in mice [36], this could be translated to humans 
where adipose sEH expression is increabetes and obesity-induced cardiovasc sed in obesity. 
A high fat diet (for 20 weeks) does not change sEH expression, but elevates sEH activity 
[37]. Inhibition of sEH, which decreased the degradation of EETs, decreased inflammation 
and lowered lipid accumulation [38]. Our results also suggest that sEH knockout mice have 
a significant body weight reduction that is associated with an increase in EETs levels (Fig. 
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7). We also observed a decrease of the inflammatory cytokines NOV and TNF-α when 
compared to WT mice. Taking all of the above information together with a decrease in 
adipogenesis, paralleled by a decrease in size of adipocytes, decreased levels of sEH could 
offer a favorable clinical approach for the treatment of obesity and associated metabolic 
disorders.
sEH is upregulated in obesity and diabetes and is associated with a decrease of EETs levels 
[39]. Increasing levels of EETs were associated with a reduction in adipocyte size in visceral 
adipose tissue, and improved glucose tolerance and insulin sensitivity, and attenuation of 
hypertension [23,28,40]. Furthermore, EETs have been shown to increase expression of 
HO-1 in adipose tissue. HO-1-mediated antioxidant mechanisms can decrease levels of ROS 
through increased levels of adiponectin [41]. The secretion of adiponectin is linked to 
increased mitochondrial function, an increase in thermogenic genes, and inhibition of 
adipogenesis [42].
Our previous studies indicated that upregulation of EETs can induce HO-1 expression and 
HO activity [16,24,43]. EETs may activate NRF2, which leads to induction of HO-1. NRF2 
activates several antioxidant genes, including HO-1 (as reviewed in [44]).
CoPP-mediated induction of HO-1 attenuated inflammatory markers and hypertension, 
decreased circulating free fatty acids and C-reactive protein and increased adiponectin 
through the activation of the AMPK-P13K- eNOS pathway [45]. Furthermore, based on our 
study, in sEH KO mice after CoPP administration exhibited in higher EETs levels, which 
illustrates the connection between HO-1 and EETs. These results are in agreement with our 
previous results that showed that the beneficial effects of EETs prevented in the presence of 
an tin mesoporphyrin (SnMP), an inhibitor of HO-activity [36].
HO-1, which is an antioxidant, decreased superoxide anions in both aorta and adipocyte 
tissue. It should be noted that HO-1-mediated antioxidant mechanism decreased levels of 
ROS with increased levels of adiponectin, which when secreted from adipocytes, can 
improve insulin action and reduce atherosclerotic processes [46]. The secretion of 
adiponectin is linked to mitochondrial function, and exerts anti-hyperglycemic effect [42]. In 
this study, we show that the level of adiponectin in sEH KO mice increased, indicating that 
there is an increase in brown-like cell in the fat, associated with a decrease of oxidative 
stress and inflammation and an increases in mitochondrial and thermogenic gene.
The third key finding is that inhibition of sEH could prevent adipocyte differentiation, which 
can moderately decrease ROS and inflammation and lead to an increase in mitochondrial 
function. However, when coupled with increased levels of HO-1, ROS and inflammation are 
fully attenuated. ROS are mostly generated from the mitochondrial respiratory chain, and 
reduce molecular oxygen to form the superoxide anion [47], which decreased dramatically 
in sEH KO mice and more dramatically after administration of CoPP. We also found that the 
level of Mfn1 increased while Mfn2 was unchanged in sEH KO mice in adipose tissue. 
Furthermore, there was an increase of COX-1 in the adipose tissue of KO mice, which marks 
an increase in mitochondrial function. Adaptive thermogenesis and mitochondrial function 
are correlated to adipocyte differentiation, and UCP-1 was also significantly upregulated in 
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sEH KO mice. All the results in our study demonstrated the positive effect of sEH inhibition 
in the reduction of inflammatory markers and decrease in ROS, which, in tur, could redirect 
more white fat into beige (brown) like fat.
From a clinical perspective, ablation of sEH expression increased beige fat over white fat 
through an increase in mitochondrial integrity and HO-1-adiponectin levels. Our study 
suggests that sEH inhibition can suppress adipogenesis in adipose tissue, prevent adipogenic 
lineage, furthermore the EETs-HO system participates in the regulation of the level of 
inflammation and ROS formation, so as to ameliorate associated diseases such as obesity, 
diabetes, cardiovascular disease. Hence, inhibition of sEH could be a novel pharmacologic 
therapeutic approach to prevent and even reverse obesity and associated metabolic disorders.
References
[1]. Vargas-Castillo A, Fuentes-Romero R, Rodriguez-Lopez LA, Torres N, Tovar AR, Understanding 
the biology of thermogenic fat: is browning a new approach to the treatment of obesity? Arch. 
Med. Res. (2017).
[2]. Abraham NG, Junge JM, Drummond GS, Translational significance of heme oxygenase in obesity 
and metabolic syndrome, Trends Pharmacol. Sci. 37 (2016) 17–36. [PubMed: 26515032] 
[3]. Kim DH, Burgess AP, Li M, Tsenovoy PL, Addabbo F, McClung JA, et al., Heme oxygenase-
mediated increases in adiponectin decrease fat content and inflammatory cytokines, tumor 
necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human 
mesenchymal stem cells, J. Pharmacol. Exp. Ther. 325 (2008) 833–840. [PubMed: 18334666] 
[4]. Ye L, Kleiner S, Wu J, Sah R, Gupta RK, Banks AS, et al., TRPV4 is a regulator of adipose 
oxidative metabolism, inflammation, and energy homeostasis, Cell 151 (2012) 96–110. [PubMed: 
23021218] 
[5]. Xie X, Sinha S, Yi Z, Langlais PR, Madan M, Bowen BP, et al., Role of adipocyte mitochondria in 
inflammation, lipemia and insulin sensitivity in humans: effects of pioglitazone treatment, Int. J. 
Obes. (Lond) (2017).
[6]. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC, Mitofusins Mfn1 and Mfn2 
coordinately regulate mitochondrial fusion and are essential for embryonic development, J. Cell 
Biol. 160 (2003) 189–200. [PubMed: 12527753] 
[7]. Loftin CD, Tiano HF, Langenbach R, Phenotypes of the COX-deficient mice indicate 
physiological and pathophysiological roles for COX-1 and COX-2, Prostaglandins Other Lipid 
Mediat. 68-69 (2002) 177–185. [PubMed: 12432917] 
[8]. Cohen P, Spiegelman BM, Brown and beige fat: molecular parts of a thermogenic machine, 
Diabetes 64 (2015) 2346–2351. [PubMed: 26050670] 
[9]. Mitschke MM, Hoffmann LS, Gnad T, Scholz D, Kruithoff K, Mayer P, et al., Increased cGMP 
promotes healthy expansion and browning of white adipose tissue, FASEB J. 27 (2013) 1621–
1630. [PubMed: 23303211] 
[10]. Lamounier-Zepter V, Look C, Schunck WH, Schlottmann I, Woischwill C, Bornstein SR, et al., 
Interaction of epoxyeicosatrienoic acids and adipocyte fatty acid-binding protein in the 
modulation of cardiomyocyte contractility, Int. J. Obes. (Lond) 39 (2015) 755–761. [PubMed: 
25370574] 
[11]. Sacerdoti D, Pesce P, Di PM, Bolognesi M, EETs and HO-1 cross-talk, Prostaglandins Other 
Lipid Mediat. 125 (2016) 65–79. [PubMed: 27354356] 
[12]. H Huang J Weng, MH Wang, EETs/sEH in diabetes and obesity-induced cardiovascular diseases. 
Prostaglandins Other Lipid Mediat. 2016 5 13 pii: S1098-8823(16)30016–8. https://doi.Org/
10.1016/j.prostaglandins.2016.05.004 [Epub ahead of print].
[13]. Bastan I, Ge XN, Dileepan M, Greenberg YG, Guedes AG, Hwang SH, et al., Inhibition of 
soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced 
gastrointestinal inflammation, J. Leukoc. Biol. (2018).
Liu et al. Page 8
Prostaglandins Other Lipid Mediat. Author manuscript; available in PMC 2019 January 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
[14]. Sacerdoti D, Abraham NG, Oyekan AO, Yang L, Gatta A, McGiff JC, Role of the heme 
oxygenases in abnormalities of the mesenteric circulation in cirrhotic rats, J. Pharmacol. Exp. 
Ther. 308 (2004) 636–643. [PubMed: 14600247] 
[15]. Sodhi K, Inoue K, Gotlinger KH, Canestraro M, Vanella L, Kim DH, et al., Epoxyeicosatrienoic 
acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice, J. Pharmacol. Exp. 
Ther. 331 (2009) 906–916. [PubMed: 19717790] 
[16]. Waldman M, Bellner L, Vanella L, Schragenheim J, Sodhi K, Singh SP, et al., 
Epoxyeicosatrienoic acids regulate adipocyte differentiation of mouse 3T3 cells, via PGC-1alpha 
activation, which is required for HO-1 expression and increased mitochondrial function, Stem 
Cells Dev. 25 (2016) 1084–1094. [PubMed: 27224420] 
[17]. Cao J, Sodhi K, Inoue K, Quilley J, Rezzani R, Rodella L, et al., Lentiviral-human heme 
oxygenase targeting endothelium improved vascular function in angiotensin II animal model of 
hypertension, Hum. Gene Ther. 22 (2011) 271–282. [PubMed: 20836698] 
[18]. Cao J, Peterson SJ, Sodhi K, Vanella L, Barbagallo I, Rodella LF, et al., Heme oxygenase gene 
targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet, 
Hypertension 60 (2012) 467–475. [PubMed: 22753217] 
[19]. Ohtoshi K, Kaneto H, Node K, Nakamura Y, Shiraiwa T, Matsuhisa M, et al., Association of 
soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients, 
Biochem. Biophys. Res. Commun. 331 (2005) 347–350. [PubMed: 15845398] 
[20]. Fasshauer M, Paschke R, Stumvoll M, Adiponectin, obesity, and cardiovascular disease, 
Biochimie 86 (2004) 779–784. [PubMed: 15589686] 
[21]. Hu J, Dziumbla S, Lin J, Bibli SI, Zukunft S, de MJ, et al., Inhibition of soluble epoxide 
hydrolase prevents diabetic retinopathy, Nature 552 (2017) 248–252. [PubMed: 29211719] 
[22]. Wagner KM, McReynolds CV, Schmidt WK, Hammock BD, Soluble Epoxide Hydrolase As a 
Therapeutic Target for Pain, Inflammatory and Neurodegenerative Diseases, 180 ed., (2017), pp. 
62–76.
[23]. Cao J, Singh SP, McClung J, Joseph G, Vanella L, Barbagallo I, et al., EET intervention on Wnt1, 
NOV and HO-1 signaling prevents obesity-induced cardiomyopathy in obese mice, Am. J. 
Physiol. Heart Circ. Physiol. 313 (2017) H368–H380. [PubMed: 28576832] 
[24]. Kim DH, Vanella L, Inoue K, Burgess A, Gotlinger K, Manthati VL, et al., Epoxyeicosatrienoic 
acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of 
HO-1-pAKT signaling and a decrease in PPARgamma, Stem Cells Dev. 19 (2010) 1863–1873. 
[PubMed: 20412023] 
[25]. Abraham NG, Jiang S, Yang L, Zand BA, Laniado-Schwartzman M, Marji J, et al., Adenoviral 
vector-mediated transfer of human heme oxygenase in rats decreases renal heme-dependent 
arachidonic acid epoxygenase activity, J. Pharmacol. Exp. Ther. 293 (2000) 494–500. [PubMed: 
10773020] 
[26]. Vanella L, Canestraro M, Lee CR, Cao J, Zeldin DC, Schwartzman ML, et al., Soluble epoxide 
hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis, 
Prostaglandins Other Lipid Mediat. (2015).
[27]. Kubisch HM, Wang J, Luche R, Carlson E, Bray TM, Epstein CJ, et al., Transgenic copper/zinc 
superoxide dismutase modulates susceptibility to type I diabetes, Proc. Natl. Acad. Sci. U. S. A. 
91 (1994) 9956–9959. [PubMed: 7937925] 
[28]. Abraham NG, Sodhi K, Silvis AM, Vanella L, Favero G, Rezzani R, et al., CYP2J2 targeting to 
endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by 
reprogramming adipocyte phenotype, Hypertension 64 (2014) 1352–1361. [PubMed: 25245389] 
[29]. Chen G, Xu R, Zhang S, Wang Y, Wang P, Edin ML, et al., CYP2J2 over-expression attenuates 
nonalcoholic fatty liver disease induced by high-fat diet in mice, Am. J. Physiol. Endocrinol. 
Metab. 308 (2015) E97–E110. [PubMed: 25389366] 
[30]. Zha W, Edin ML, Vendrov KC, Schuck RN, Lih FB, Jat JL, et al., Functional characterization of 
cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity, J. Lipid Res. 55 
(2014) 2124–2136. [PubMed: 25114171] 
Liu et al. Page 9
Prostaglandins Other Lipid Mediat. Author manuscript; available in PMC 2019 January 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
[31]. Singh SP, Schragenheim J, Cao J, Falck JR, Abraham NG, Bellner L, PGC-1 alpha regulates 
HO-1 expression, mitochondrial dynamics and biogenesis: Role of epoxyeicosatrienoic acid, 
Prostaglandins Other Lipid Mediat. 125 (2016) 8–18. [PubMed: 27418542] 
[32]. Peterson SJ, Kim DH, Li M, Positano V, Vanella L, Rodella LF, et al., The L-4F mimetic peptide 
prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice, 
J. Lipid Res. 50 (2009) 1293–1304. [PubMed: 19224872] 
[33]. Nicolai A, Li M, Kim DH, Peterson SJ, Vanella L, Positano V, et al., Heme oxygenase-1 
induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic 
rats, Hypertension 53 (2009) 508–515. [PubMed: 19171794] 
[34]. Burgess A, Li M, Vanella L, Kim DH, Rezzani R, Rodella L, et al., Adipocyte heme oxygenase-1 
induction attenuates metabolic syndrome in both male and female obese mice, Hypertension 56 
(2010) 1124–1130. [PubMed: 21041703] 
[35]. Olearczyk JJ, Quigley JE, Mitchell BC, Yamamoto T, Kim IH, Newman JW, et al., 
Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects 
the kidney from damage in hypertensive Goto-Kakizaki rats, Clin Sci (Lond) 116 (2009) 61–70. 
[PubMed: 18459944] 
[36]. Sodhi K, Puri N, Inoue K, Falck JR, Schwartzman ML, Abraham NG, EET agonist prevents 
adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an 
increase in HO-1 levels, Prost Other Lipid Mediat 98 (2012) 133–142.
[37]. De Taeye BM, Morisseau C, Coyle J, Covington JW, Luria A, Yang J, et al., Expression and 
regulation of soluble epoxide hydrolase in adipose tissue, Obesity 18 (2010) 489–498 Silver 
Spring. [PubMed: 19644452] 
[38]. Zhang LN, Vincelette J, Cheng Y, Mehra U, Chen D, Anandan SK, et al., Inhibition of soluble 
epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and 
dyslipidemia, Arterioscler. Thromb. Vasc. Biol. 29 (2009) 1265–1270. [PubMed: 19667112] 
[39]. Imig JD, Hammock BD, Soluble epoxide hydrolase as a therapeutic target for cardiovascular 
diseases, Nat. Rev. Drug Discov. 8 (2009) 794–805. [PubMed: 19794443] 
[40]. Bettaieb A, Koike S, Hsu MF, Ito Y, Chahed S, Bachaalany S, et al., Soluble epoxide hydrolase in 
podocytes is a significant contributor to renal function under hyperglycemia, Biochim. Biophys. 
Acta 1861 (2017) 2758–2765.
[41]. Peterson SJ, Frishman WH, Targeting heme oxygenase: therapeutic implications for diseases of 
the cardiovascular system, Cardiol. Rev 17 (2009) 99–111. [PubMed: 19384082] 
[42]. Cheng CF, Lian WS, Chen SH, Lai PF, Li HF, Lan YF, et al., Protective effects of adiponectin 
against renal ischemia-reperfusion injury via prostacyclin -PPARalpha- heme oxygenase-1 
signaling pathway, J. Cell. Physiol. (2011).
[43]. Vanella L, Kim DH, Sodhi K, Barbagallo I, Burgess AP, Falck JR, et al., Crosstalk between EET 
and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell 
derived adipocytes, Prostaglandins Other Lipid Mediat. 96 (2011) 54–62. [PubMed: 21821145] 
[44]. Araujo JA, Zhang M, Yin F, Heme oxygenase-1, oxidation, inflammation, and atherosclerosis, 
Front. Pharmacol. 3 (2012) 119. [PubMed: 22833723] 
[45]. Stec DE, Ishikawa K, Sacerdoti D, Abraham NG, The emerging role of heme oxygenase and its 
metabolites in the regulation of cardiovascular function, Int. J. Hypertens. (2012) 5935302012.
[46]. Goldstein BJ, Scalia R, Adiponectin: a novel adipokine linking adipocytes and vascular function, 
J. Clin. Endocrinol. Metab. 89 (2004) 2563–2568. [PubMed: 15181024] 
[47]. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, et al., Extension of 
murine life span by overexpression of catalase targeted to mitochondria, Science 308 (2005) 
1909–1911. [PubMed: 15879174] 
Liu et al. Page 10
Prostaglandins Other Lipid Mediat. Author manuscript; available in PMC 2019 January 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 1. 
Effect of EETs and sEH inhibition on oil droplets formation in MSCs derived adipocytes. 
We measured the effect of EETs administration and suppression of sEH on adipogenesis. 
Daily supplementation of 11, 12-, and 14, 15-EETs was effective on adipogenesis 
suppression at 14 days. Inhibition of sEH with AUDA, showed a significant (p < 0.05) and 
synergistic reduction of lipid droplets formation in MSC-derived adipocytes. (n = 4), #p < 
0.05 vs. control, ** p < 0.05 vs. control.
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Fig. 2. 
Effect of sEH deletion on oil droplet formation. Ablation of sEH significantly (p < 0.05) 
decreased lipid droplets size in MSC derived adipocytes. The percentage of cells with 
morphological lipid droplets decreased following silencing sEH. The effect of siRNA on 
adipogenesis was determined by counting cells with lipid droplets in the cytoplasm and cells 
positive for the lipid-specific dye. The adipocyte cell size in the absence of siRNA was ± 
pixels compared with ± pixels in the presence of siRNA. (n = 4), #p < 0.05 vs. control.
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Fig. 3. 
Effect of sEH knockout on Inflammatory Cytokine levels in adipose tissue and 
mitochondria. RT_PCR analysis showed significant (p < 0.05) increase in HO-1 mRNA 
expression in adipose tissue of sEH KO mice as compared to WT control mice (Fig. 3A), the 
mRNA expression of inflammatory cytokines such as NOV and TNFα were significantly 
lower in sEH mice compared to control (Fig. 3B and 3C). These results indicate that 
inhibition of sEH leads to HO-1 induction resulting in a decrease of inflammation. We 
measured Mfn1 and 2 levels in adipose tissue of sEH KO mice. The results showed a 
significant (p < 0.05) increase in Mfn1 mRNA expression in sEH KO mice compared to 
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control. However, there is no significant change in Mfn2 expression (Fig. 3D and E). 
Furthermore, levels of cytochrome c oxidase subunit I (COX-I) were significantly higher in 
KO mice (Fig. 3F), and expression of FIS1 was not significantly different between groups 
(Fig. 3G). Moreover, adiponectin mRNA expression significantly increased in sEH KO mice 
(Fig. 3H and I). (n = 4), * p < 0.05 vs.WT.
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Fig. 4. 
Effect of sEH knockout on Mitochondrial Function in aorta. In agreement with the results 
from the fat tissue, we observed a significant (p < 0.05) increase in HO-1 (Fig. 4B) as well 
as in Mfn1 (Fig. 4A) expression in the aortas of sEH KO mice as compared to control. These 
results indicate that inhibition of sEH resulted in an increase in mitochondrial function. 
Ablation of sEH and HO-1 induction significantly reduced superoxide anion formation in 
aortas of mice compared to both KO sEH and WT control (Fig. 4C). (n = 4), * p < 0.05 
vs.WT, #p < 0.05 vs sEH KO.
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Fig. 5. 
Effect of sEH ablation with and without HO-1 Inducer on Adiposity. Deletion of sEH 
decreased body weight in male null mice compared to control. Picture of mice indicated that 
sEH KO mice are leaner than control group (Fig. 5A). Body weight of KO mice were 28.8 
± 7.28 g compared with 36.17 ± 0.77 g of control mice (Fig. 5B). To further increase the 
antioxidant functions of EETs, we treated sEH KO mice with a well-known HO-1 inducer 
(CoPP). Western blot analysis showed significant (p < 0.05) increase in HO-1 protein 
expression in adipose tissue of sEH KO mice as compared to WT control mice, this increase 
was even more significant when CoPP treatment was given to sEH KO mice (Fig. 5C).The 
body weight in sEH null mice was similar to sEH + CoPP group. (n = 4), * p < 0.05 vs.WT, 
#p < 0.05 vs sEH KO.
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Fig. 6. 
Effect of sEH ablation and HO-1 induction on EETs levels. The levels of isoforms of EETs 
(5, 6-EET, 8, 9-EET, 11, 12-EET, 14, 15-EET) and the total EETs (2.32 ± 0.22 mg vs. 0.61 
± 0.06 mg) levels were significantly (p < 0.05) increased in sEH KO mice compared to 
control mice. Since not all EETs are released as functional EETs, we decided to inject CoPP, 
a potent HO-1 inducer, to KO mice. As a result, we observed that administration of CoPP 
lead to a significant increase in all forms of EETs (5, 6-EET, 8, 9-EET, 11, 12-EET, 14, 15-
EET) as well as total EETs levels compared to control mice and sEH KO without CoPP (Fig. 
6A–F) (n = 4), * p < 0.05 vs.WT male, #p < 0.05 vs sEH (−/−) male.
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Fig. 7. 
Schematic Representation of the Effect of EET and HO-1 on ROS, mitochondrial function 
and thermogenesis. AA-derived epoxides (Epoxyeicosatrienoic acid, EET) through CYP 
pathway could rapidly degrade EET into less active DHET by soluble epoxide hydrolase 
(sEH), and inhibitions of sEH could upregulate EET concentration and induce HO-1 activity. 
Stem cell derived small adipocytes turned into large adipocyte with the upregulated level of 
inflammation and ROS with mitochondrial dysfunction, while EET-HO correlated with 
decreased inflammation and reduce ROS, paralleled by the size decrease of adipocytes to 
prevent adipocyte differentiation. EET and HO-1 could also improve mitochondrial function 
by upregulating Mfn1 and COX-1, associated with an adaptive thermogenesis. All these 
benefits will result in to ameliorate adipocyte associated diseases such as obesity and 
cardiovascular diseases.
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